Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).

News / Press Releases

: Tonix In The News

Home
Investors
News / Press Releases
Tonix In The News

Tonix In The News

Tonix Pharmaceuticals developing treatment for underserved PTSD patients

MedCity News |

June 23, 2014

Tonix Gets IND Clearance from FDA for PTSD Treatment

Drug Delivery & Development |

June 11, 2014

Tonix receives IND approval for sublingual formulation to treat PTSD

Fierce Drug Delivery |

June 10, 2014

Tonix's sublingual formulation for fibromyalgia reaches pivotal trial stage

Fierce Drug Delivery |

May 13, 2014

Fibromyalgia Drugs: Successes or Failures?

National Pain Report |

April 23, 2014

Seth Lederman's Tonix Pharmaceuticals taking shorter path to drug approval

New York Business Journal |

April 4, 2014

Seth Lederman: Turning something old into something new (Part 2 of 2)

DDN News |

March 14, 2014

Tonix CEO: Investors Seeing Value in Reformulation Strategy

TheStreet |

February 14, 2014

Seth Lederman: Looking to past medications for the future (Part 1 of 2)